Get started
Author

M. B. Nienhuis

Observed names: Mitch Nienhuis, Mitchell Nienhuis
ORCID: 0000-0002-0526-6321
Observed ORCID: 0000-0002-0526-6321
OpenAlex ID: A5111036593
A comparison of three-dimensional kinematics between markerless and marker-based motion capture in overground gait
2023 · Zachary Ripic, Mitch Nienhuis, et al. · Journal of Biomechanics · 51
Validity of artificial intelligence-based markerless motion capture system for clinical gait analysis: Spatiotemporal results in healthy adults and adults with Parkinson’s disease
2023 · Zachary Ripic, Joseph F. Signorile, et al. · Journal of Biomechanics · 32
Supplementation Strategies for Strength and Power Athletes: Carbohydrate, Protein, and Amino Acid Ingestion
2024 · Stephen P. Bird, Mitch Nienhuis, et al. · Nutrients · 27
Reliability of artificial intelligence-driven markerless motion capture in gait analyses of healthy adults
2025 · Brandon Schoenwether, Zachary Ripic, et al. · PLoS ONE · 19
PDF
An unusual cause of T-wave inversion
2007 · M. B. Nienhuis, J. P. Ottervanger, et al. · Netherlands Heart Journal · 1
Evaluation of automatic identification of events during the lunge exercise using kinematic data
2026 · Mitchell Nienhuis, Joseph Signorile, et al. · Journal of Biomechanics
Clinical impact of off-label use of contemporary drug-eluting stents in the randomized TWENTE trial
2013 · H. Sen, K. Tandjung, et al. · European Heart Journal
Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting Xience V stents: two-year clinical outcome in the gender-stratified randomized, controlled TWENTE trial
2013 · K. Tandjung, H. Sen, et al. · European Heart Journal
Works count: 8
Citation count: 130
H-index: 4
I10-index: 4
Year
Topic
Type